Borrelia Burgdorferi Bacterin-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract
444 adverse event reports submitted to the FDA
Important: Adverse event reports do not establish that a drug caused or contributed to the event. Consult your veterinarian before making treatment decisions.
444
Total Reports
16
Deaths Reported
360.0%
Death Rate
Active Ingredients
Borrelia Burgdorferi Bacterin-Leptospira Canicola-Grippotyphosa-Icterohaemorrhagiae-Pomona Bacterial Extract
Administration Routes
SubcutaneousParenteralUnknownOtherOralAuricular (Otic)
Species Affected
Dog 444
Most Affected Breeds
Retriever - Labrador 75
Retriever - Golden 49
Shepherd Dog - German 24
Crossbred Canine/dog 24
Shepherd Dog - Australian 16
Siberian Husky 14
Shih Tzu 11
Poodle (unspecified) 11
Pit Bull 9
Boxer (German Boxer) 8
Most Reported Reactions
Lack of efficacy (bacteria) - Borrelia 235
Other abnormal test result NOS 88
Lack of efficacy (ectoparasite) - tick NOS 81
Vomiting 42
Diarrhoea 33
Lethargy (see also Central nervous system depression in Neurological) 30
Partial lack of efficacy 26
Lethargy (see also Central nervous system depression in 'Neurological') 23
Lack of efficacy (bacteria) - Anaplasma 21
Lameness 18
Not eating 17
Proteinuria 15
Outcome Breakdown
Outcome Unknown
318 (71.6%)
Ongoing
57 (12.8%)
Recovered/Normal
53 (11.9%)
Euthanized
11 (2.5%)
Died
5 (1.1%)
Source: FDA Center for Veterinary Medicine — Adverse Event Reports. Data reflects voluntary submissions and may not represent actual incidence rates.